Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Veracyte Announces New Preliminary Data For Its In-Development Lung Cancer Portfolio Tests

Wed 16th December, 2020 6:34pm
Dec 16 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES NEW PRELIMINARY DATA FOR ITS
IN-DEVELOPMENT
LUNG CANCER PORTFOLIO TESTS
    * VERACYTE INC - NONINVASIVE NASAL SWAB TEST AND ITS
PERCEPTA
GENOMIC ATLAS ARE IN DEVELOPMENT AND SCHEDULED TO LAUNCH IN
SECOND HALF OF 2021

Source text for Eikon:  urn:newsml:reuters.com:*:nBw7MgDtma
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.